FREAMINE HBC 6.9% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Freamine Hbc 6.9%, and when can generic versions of Freamine Hbc 6.9% launch?
Freamine Hbc 6.9% is a drug marketed by B Braun and is included in one NDA.
The generic ingredient in FREAMINE HBC 6.9% is amino acids. There are three hundred and fifty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Freamine Hbc 6.9%
A generic version of FREAMINE HBC 6.9% was approved as amino acids by B BRAUN on April 13th, 2012.
Summary for FREAMINE HBC 6.9%
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FREAMINE HBC 6.9% at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for FREAMINE HBC 6.9%
US Patents and Regulatory Information for FREAMINE HBC 6.9%
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B Braun | FREAMINE HBC 6.9% | amino acids | INJECTABLE;INJECTION | 016822-006 | May 17, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |